NASDAQ$TMCI

Treace Medical Concepts Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Reports in 3 weeks

Treace hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2026

    Revenue
    $47.2M
    EPS
    -$0.28
  • Year-ago · Q2 2024

    Q2 2024

    Revenue
    $44.5M
    EPS
    -$0.34
  • FY2025 consensus

    Analyst consensus

    Revenue
    $226M
    EPS
    -$0.74

Revenue & EPS history

Treace · Revenue · Quarterly

$47.2M

Q1 2026-10.2%vs Q1 2025
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-5.8%

Avg return

Earnings day

-5.9%

Avg return

5 days after

-3.7%

Avg return

30 days after

33%

7 / 21 earnings

Positive

+43.3%

Q3 2024

Best reaction

-62.8%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.7%+31.8%+82.3%
Q4 2025-11.0%-30.0%-41.9%
Q3 2025-28.6%-46.6%-56.0%
Q1 2025-9.5%-10.9%-22.9%
Q4 2024-2.1%+0.0%-7.4%
Q3 2024+43.3%+48.1%+42.7%
Q2 2024+2.7%-8.5%-13.9%
Q1 2024-62.8%-60.9%-45.5%
Q4 2023-5.7%-6.4%-8.9%
Q3 2023-42.1%-32.0%-11.4%
Q2 2023-16.9%-20.3%-31.3%
Q1 2023-5.5%-4.9%-0.9%
Q4 2022+21.1%+19.0%+37.5%
Q3 2022+1.9%+16.1%+13.7%
Q2 2022-1.3%+1.0%+10.1%
Q1 2022-14.4%-30.2%-9.3%
Q4 2021-1.0%-7.4%-5.7%
Q3 2021-0.8%-6.6%-28.5%
Q2 2021-3.3%-5.9%-3.2%
Q4 2020+4.7%+14.9%+11.5%
Q1 2021+4.7%+14.9%+11.5%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro